BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36090643)

  • 1. Efficacy evaluation of surgery combined with chemotherapy for stage IIIA small cell lung cancer patients: a retrospective analysis.
    Bian D; Jiang S; Xiong Y; Qi M; Wu J; Addeo A; Yamauchi Y; Manapov F; Dempke WCM; Vannucci J; Di Federico A; Xu X; Chen L
    Transl Lung Cancer Res; 2022 Aug; 11(8):1631-1642. PubMed ID: 36090643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
    Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
    Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobectomy versus sublobar resection for stage I (T1-T2aN0M0) small cell lung cancer: A SEER population-based propensity score matching analysis.
    Zhou N; Yang L; Zhang B; Zhu S; Huo H; He J; Zu L; Song Z; Xu S
    Cancer Med; 2023 Apr; 12(7):7923-7931. PubMed ID: 36567517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for stage IIB-IIIB small cell lung cancer.
    Huang Z; Liu Y; Wang S; Ai K; Zhang P
    World J Surg Oncol; 2023 Oct; 21(1):333. PubMed ID: 37872542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
    Gao L; Shen L; Wang K; Lu S
    Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.
    Liu Y; Shan L; Shen J; Liu L; Wang J; He J; He Q; Jiang L; Guo M; Chen X; Zeng H; Xia X; Peng G; Liang W; He J
    Thorac Cancer; 2019 Apr; 10(4):593-600. PubMed ID: 30854808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic Analysis of Lobectomy versus Sublobar Resection in Patients Aged ≥60 Years with Stage Ia Small Cell Lung Cancer].
    Zeng H; Liu Y; Xia X; Li J; He J
    Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):8-15. PubMed ID: 29357967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
    Yang H; Wang K; Li S; Li Y; Yuan L
    Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
    [No Abstract]   [Full Text] [Related]  

  • 9. Sublobar resection versus lobectomy for patients with stage T1-2N0M0 pulmonary typical carcinoid tumours: a population-based propensity score matching analysis.
    Yang H; Mei T
    Interact Cardiovasc Thorac Surg; 2022 Aug; 35(3):. PubMed ID: 35512177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery as a Potential Treatment Option for Patients With Stage III Small-Cell Lung Cancer: A Propensity Score Matching Analysis.
    Zhang C; Li C; Shang X; Lin J; Wang H
    Front Oncol; 2019; 9():1339. PubMed ID: 31850223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
    Xu L; Zhang G; Song S; Zheng Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
    Xu YJ; Zheng H; Gao W; Jiang GN; Xie HK; Chen C; Fei K
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):887-93. PubMed ID: 25156899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of neoadjuvant immunotherapy combined with chemotherapy followed by surgical resection in patients with stage I-IIIA small-cell lung cancer: a retrospective single-arm clinical trial.
    Liu J; Wang L; Shu W; Zhang L; Wang Y; Lv W; Zhu L; Hu J
    J Thorac Dis; 2022 Nov; 14(11):4405-4415. PubMed ID: 36524062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study.
    Yang H; Xiao X; Mei T; Zhou P
    Aging Clin Exp Res; 2022 Aug; 34(8):1925-1934. PubMed ID: 35347580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy Following Surgical Resection Improves Survival in Patients With Early Stage Small Cell Lung Cancer.
    Yao Y; Zhou Y; Yang Z; Huang H; Shen H
    Oncol Res; 2019 Feb; 27(2):203-210. PubMed ID: 29523217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study.
    Zhang R; Cai L; Wang G; Wen Y; Wang F; Zhou N; Zhang X; Huang Z; Yu X; Xi K; Yang L; Zhao D; Lin Y; Zhang L
    Front Oncol; 2019; 9():1552. PubMed ID: 32117785
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysis.
    Ning J; Ge T; Zhu S; Han Y; Ruan S; Ma Y; Liu R
    Front Oncol; 2022; 12():958187. PubMed ID: 36249007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery
    Liu L; Li R; Peng Y; Zhang T; Qiu B
    J Thorac Dis; 2023 May; 15(5):2769-2778. PubMed ID: 37324082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).
    Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR
    Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.